期刊文献+

中西医结合治疗系统性红斑狼疮的临床观察及发病机制探讨 被引量:10

Effect of Integrated Chinese-western Therapy in Systemic Lupus Erythematosus
暂未订购
导出
摘要 目的观察中西医联合治疗系统性红斑狼疮的临床疗效,并初步探讨T淋巴细胞亚群与该病发病机制的关系。方法将我院收治的33例SLE患者随机分为对照组和治疗组,对照组采用常规激素与CTX治疗,治疗组在对照组基础上加用中药益气养血健脾补肾方。观察患者治疗前后免疫指标及血常规变化,并针对T淋巴细胞亚群的变化水平分析与SLE之间的关系。结果经过治疗后,治疗组总有效率为94.4%,对照组为80.0%,治疗组显著高于对照组(P<0.05);治疗组抗ds-DNA、ANA、抗-RNP、CIC转阴率显著优于高于对照组(P<0.05)。两组患者治疗后免疫球蛋白及相关补体均较治疗前显著下降(P<0.05);其中治疗组免疫球蛋白IgM、IgA、IgG下降水平明显优于对照组,两组间具有统计学差异(P<0.05),而相关补体C3、C4下降水平无统计学差异(P>0.05);两组患者治疗后CD4与CD4/CD8均明显升高(P<0.05)。结论 T淋巴细胞亚群可能SLE的发病有关,益气养血健脾补肾方联合西药治疗SLE疗效确切,值得临床推广。 Objective To observe the clinical effect of integrated Chinese - western medicine in treating SLE , and investigate the rela- tionship of T lymphocyte subsets and the pathogenesis of the disease. Methods 33 cases of SLE patients were randomly divided into control group and treatment group , the control group treated by routine hormone and CTX, the treatment group treated the same as control group and Chinese medicine. Observe the changes of immune indexes and blood of patients before and after treatment, and analyze the relationship be- tween SLE and level change of subsets of T lymph bacteria. Results After treatment, the total effective rate of treatment group was 94.4%, 80% in the control group, the treatment group was significantly higher than that of the control group(P 〈 0.05), The treatment group of ds - DNA, ANA, - RNP, CIC negative conversion rate was significantly higher than that of control group( P 〈 0.05 ), Two groups of patients af- ter treatment with immunoglobulin and complement significantly lower than before treatment (P 〈 0.05 ) ; treatment group of immunoglobulin IgM, IgA, IgG decrease was significantly better than the control group, with significant difference between the two groups (P 〈 0.05), and complement C3, C4 no significant precipitation flat the difference ( P 〉 0.05 ) ; the two group patients after CD4 and CIM/CD8 were signifi- cantly increased ( P 〈 0.05 ). Conclusion T lymph bacterial subpopulations may effect SLE pathogenesis, integrated Chinese - western ther- apy SLE is better than only western medicine , and worth the clinical promotion.
作者 邹里彬
出处 《湖北中医药大学学报》 2013年第4期25-27,共3页 Journal of Hubei University of Chinese Medicine
关键词 系统性红斑狼疮 中西医结合疗法 益气养血健脾补肾方 SLE Integrated Chinese -western therapy supply Qi and blood and strengthen spleen and kidney decoction
  • 相关文献

参考文献11

二级参考文献85

  • 1李媛,齐文成,戚务芳.亚急性皮肤型红斑狼疮误诊为银屑病一例[J].中国全科医学,2005,8(12):1030-1030. 被引量:1
  • 2李东升,王玮蓁,孙春艳,戴明,朱林学,段逸群.系统性红斑狼疮患者B淋巴细胞刺激因子及其受体BAFF-R的表达[J].中华皮肤科杂志,2006,39(1):10-12. 被引量:13
  • 3徐刚,余开梅,刘美琳,施菁玲.73例亚急性皮肤型红斑狼疮患者临床分析[J].中国麻风皮肤病杂志,2007,23(1):28-29. 被引量:6
  • 4Hahne M,Kataoka T,Schroter M,et al.APRIL a new ligand of the tumor necrosis factor family,stimulates tumor cell growth.J Exp Med 1998;188:1185-1190.
  • 5Parrish-Novak J,Foster DC,Holly RD,et al.Interleukin-21 and the IL-21 receptor:novel effectors of NK and T cell responses.J Leukoc Biol 2002;72:856-863.
  • 6Parrish-Novak J,Dillon SR,Nelson A,et al.Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function.Nature 2000;408:57-63.
  • 7Bombardier C,Gladman DD,Urowitz MB,et al.Derivation of the SLEDAI.A disease activity index for lupus patients.The committee on prognosis studies in SLE.Arthritis Rheum 1992;35:630-640.
  • 8Stohl W.Therapeutic targeting of B lymphocyte stimulator (BLyS) in the rheumatic diseases.Endocr Metab Immune Disord Drug Targets 2006;6:351-358.
  • 9Koyama T,Tsukamoto H,Masumoto K,et al.A novel polymorphism of the human APRIL gene is associated with systemic lupus erythematosus.Rheumatology (Oxford) 2003;42:980-985.
  • 10Ozaki K,Spolski R,Ettinger R,et al.Regulation of B cell differentiation and plasma cell generation by IL-21,a novel inducer of Blimp-1 and Bcl-6.J Immunol 2004;173:5361-5371.

共引文献42

同被引文献73

引证文献10

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部